Part A – AI-Designed Protein Binders Tackle a Century-Old Challenge: Tc24 as a Universal Vaccine Antigen for Chagas Disease Part B – Expression, Purification and Biophysical Characterisation of de novo binders designed against the Flagellar Calcium Binding Protein, Tc24

Richardson, Alicia (2025) Part A – AI-Designed Protein Binders Tackle a Century-Old Challenge: Tc24 as a Universal Vaccine Antigen for Chagas Disease Part B – Expression, Purification and Biophysical Characterisation of de novo binders designed against the Flagellar Calcium Binding Protein, Tc24. MRes thesis, University of Nottingham.

[thumbnail of Alicia Richardson.pdf]
Preview
PDF (Thesis - as examined) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Available under Licence Creative Commons Attribution.
Download (4MB) | Preview

Abstract

Part A – Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, remains one of the most

neglected tropical diseases, disproportionately affecting low-income, rural populations across

Latin America. Despite over a century since its discovery, there is still no effective vaccine and

therapies currently rely on the usage of nifurtimox and benznidazole, which have been linked

to severe side effects. This review explores the multifaceted challenges of developing both a

therapeutic and prophylactic treatment for Chagas disease. Particular attention is given to the

flagellar calcium-binding protein Tc24, a highly conserved, immunogen expressed across all

morphological stages of T. cruzi.

In parallel, this review examines how artificial intelligence (AI) and deep learning (DL)

platforms are revolutionising structural prediction and binder design. These technologies

enable the in silico development of both high-affinity and target-specific binders at low cost.

In summary, this review proposes the integration of conserved antigen targets, with AI-guided

binder design presents a novel framework for overcoming current barriers in vaccine

development, offering renewed hope for the prevention and management of Chagas disease. 

Part B – Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, remains one of the most

neglected tropical diseases, disproportionately effecting affecting socioeconomically

impoverished regions across Latin America. Despite over a century of research since its

discovery, there is still no effective vaccine, and current therapies rely on the usage of

nifurtimox and benznidazole which have been linked to severe side effects. Tc24, a highly

conserved flagellar calcium binding protein remains an attractive vaccine candidate.

This study experimentally evaluated six RFdiffusion designed binders against Tc24. Although

no functional binders were identified, these results highlight limitations of current binder

design pipelines and emphasise the need for incorporating solubility parameters in future Tc24

binder development.

Item Type: Thesis (University of Nottingham only) (MRes)
Supervisors: Campeotto, Ivan
Harding, Stephen
Keywords: Trypanosoma cruzi, Chagas, RFdiffusion, de novo protein, Neglected tropical disease (NTD)
Subjects: R Medicine > RC Internal medicine
Faculties/Schools: UK Campuses > Faculty of Science > School of Biosciences
Item ID: 82736
Depositing User: Richardson, Miss Alicia
Date Deposited: 12 Dec 2025 04:40
Last Modified: 12 Dec 2025 04:40
URI: https://eprints.nottingham.ac.uk/id/eprint/82736

Actions (Archive Staff Only)

Edit View Edit View